CTVA

Corteva Inc

Add to Watchlist

Advanced Chart

67.790

+0.930(+1.390%)

Overview
Forecast
Valuation

Line

Candle

YTD

High

67.930

Open

66.710

VWAP

67.69

Vol

4.29M

Mkt Cap

46.24B

Low

66.5684

Amount

290.35M

EV/EBITDA(TTM)

13.96

Total Shares

696.98M

48.56B

EV/OCF(TTM)

17.34

P/S(TTM)

2.78

Corteva, Inc. is a global pure-play agriculture company. The Company is a global provider of seed and crop protection solutions focused on the agriculture industry and contributing to a healthier food supply. The Company's Seed segment is developing and supplying advanced germplasm and traits that produce optimum yield for farms around the world. The segment is engaged in the seed markets, such as North America corn and soybeans, Europe corn and sunflower, as well as Brazil, India, South Africa, and Argentina corn. The segment also offers trait technologies that improve resistance to weather, disease, insects and enhance food. The Company's Crop Protection segment offers crop protection solutions and digital solutions that provide farmers with the tools they need to improve productivity and profitability, and help keep fields free of weeds, insects and diseases. The segment offers herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides and biologicals.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

4.16B

+4.69%

0.369

+15.29%

2.43B

+4.56%

-0.358

-26.93%

6.25B

+2.19%

1.881

+2.8%

Estimates Revision

The market is revising Upward the revenue expectations for Corteva, Inc. (CTVA) for FY2025, with the revenue forecasts being adjusted by 0.25% over the past three months. During the same period, the stock price has changed by 9.23%.

Revenue Estimates for FY2025

Revise Upward

+0.25%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-0.15%

In Past 3 Month

Stock Price

Go Up

+9.23%

In Past 3 Month

12 Analyst Rating

3.63% Upside

Wall Street analysts forecast CTVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CTVA is 70.25 USD with a low forecast of 59.00 USD and a high forecast of 74.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

10 Buy

2 Hold

0 Sell

Strong Buy

3.63% Upside

Current: 67.790

Low

59.00

Averages

70.25

High

74.00

3.63% Upside

Current: 67.790

Low

59.00

Averages

70.25

High

74.00

Keybanc

Aleksey Yefremov

Buy

Maintains

$71 → $72

2025-05-09

New

Reason

Keybanc

Aleksey Yefremov

Price Target

$71 → $72

2025-05-09

New

Maintains

Buy

Reason

Citigroup

Patrick Cunningham

Strong Buy

Maintains

$75 → $78

2025-05-09

New

Reason

Citigroup

Patrick Cunningham

Price Target

$75 → $78

2025-05-09

New

Maintains

Strong Buy

Reason

Morgan Stanley

Vincent Andrews

Buy

Maintains

$65 → $71

2025-05-09

New

Reason

Morgan Stanley

Vincent Andrews

Price Target

$65 → $71

2025-05-09

New

Maintains

Buy

Reason

Oppenheimer

Kristen Owen

Buy

Reiterates

$72 → $75

2025-05-09

New

Reason

Oppenheimer

Kristen Owen

Price Target

$72 → $75

2025-05-09

New

Reiterates

Buy

Reason

UBS

Joshua Spector

Strong Buy

Maintains

$74 → $76

2025-05-08

New

Reason

UBS

Joshua Spector

Price Target

$74 → $76

2025-05-08

New

Maintains

Strong Buy

Reason

Keybanc

Bradley Thomas

Buy

Maintains

$70 → $71

2025-04-14

Reason

Keybanc

Bradley Thomas

Price Target

$70 → $71

2025-04-14

Maintains

Buy

Reason

KeyBanc analyst Aleksey Yefremov raised the firm's price target on Corteva to $71 from $70 and keeps an Overweight rating on the shares. The firm thinks updates on observed effect of the tariffs on demand in April/May would be consequential for chemical names during Q1 earnings season, while Q1 results and 2025 guidance are now a bit less relevant. Other new major topics KeyBanc expects to be discussed are exposure to U.S. imports of raw materials from high-tariff countries and any outlook on pricing actions to offset higher costs. Further, the firm also expects most companies to see early signs of slower demand, with several data points indicating weak trends in March likely only softened in April.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Corteva Inc (CTVA.N) is 22.55, compared to its 5-year average forward P/E of 19.93. For a more detailed relative valuation and DCF analysis to assess Corteva Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Overvalued

5Y Average PE

19.93

Current PE

22.55

Overvalued PE

21.95

Undervalued PE

17.91

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

11.72

Current EV/EBITDA

12.68

Overvalued EV/EBITDA

12.92

Undervalued EV/EBITDA

10.52

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Overvalued

5Y Average PS

2.14

Current PS

2.62

Overvalued PS

2.44

Undervalued PS

1.85